Digital Transformation

This evolution of healthcare involves using technology to improve diagnosis, treatments, monitor patients, enhance hospital operations and culture, and bolster consumer-focused care. This includes virtual reality tools, wearable devices, workflow software, health apps and other digital health tools.

Xtant Medical and Pinnacle Spine Group Announce Distribution Agreement, Expanding the Availability of Innovative InFill® Lateral Fusion System

BELGRADE, Mont. and DALLAS, June 08, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of regenerative medicine products and medical devices and Pinnacle Spine Group, LLC, a developer of innovative spinal fusion solutions, today announced a joint agreement to expand distribution of Pinnacle's InFill® Lateral Lumbar Interbody Fusion System. Through this agreement, Xtant enters the lateral lumbar interbody fusion market, expanding its spinal hardware portfolio.

Thumbnail

Enable Injections Completes Cincinnati Manufacturing Facility for On Body Delivery Systems

SAN FRANCISCO, June 07, 2016 (GLOBE NEWSWIRE) -- Enable Injections Inc., the developer of wearable medical devices that enable easy, at-home self-administration of high volume injectable drugs and biologics, opens its new Cincinnati manufacturing facility this month, the company announced today at the BIO meeting in San Francisco.

Zimmer Biomet to acquire LDR to enhance innovation and growth of spine business

Zimmer Biomet Holdings Inc., a global provider of musculoskeletal healthcare, and LDR Holding Corporation, a global medical device company, have announced that both boards of directors have approved a definitive agreement under which Zimmer Biomet acquire all the outstanding shares of LDR for $37 per share in cash, a value of approximately $1 billion. 

Sensoria Introduces Smarter Upper Body Garments and Announces Updates to Sensoria Fitness App

REDMOND, Wash., June 07, 2016 (GLOBE NEWSWIRE) -- Sensoria Inc., a world leader in wearable fitness and smart garment technology, is introducing its new smart line of colorful sports bras and t-shirts and training plans offered through a new version of the Sensoria Fitness v2.0 app. The new app, which will feature a cardiologist-created and tested algorithm called Heart Sentinel™,  connects to heart rate monitoring (HRM) garments and may detect certain cardiac irregularities that often precede catastrophic events. The new garments are designed to meet the needs of all levels of fitness enthusiasts by including a new medium support sports bra for women and a new short sleeve t-shirt for men.

Going live: ONC unveils website with cost, quality info for health IT products

The U.S. Department of Health and Human Services Office of the National Coordinator for Health Information Technology unveiled a website offering more detailed and easier-to-understand information about certified health IT products.

Grand Rounds CEO sees potential in healthcare IT

In an interview with TechCrunch, Grand Rounds CEO and co-founder Owen Tripp, talks about evaluating candidates, healthcare startups and the prominence of women in healthcare IT.

Change Healthcare, SourceMed to partner on billing for outpatient healthcare providers

Change Healthcare, a provider of software and analytics and technology-enabled services, has announced a partnership with SourceMed, a provider of outpatient software solutions and revenue cycle management services for surgery centers.

Ransomware attacks challenge healthcare IT

The healthcare industry has seen ransomware attacks on the rise in recent months.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.